The Pharmaceutical Intellectual Property and Competition Law Review

Written By

sally shorthose module
Sally Shorthose

Partner
UK

As one of our firm's most experienced intellectual property partners, specialising in transactional IP matters, I offer a wealth of knowledge to businesses at the cutting edge of research, development and technology, in a variety of sectors for which IP is of prime importance.

peter willis Module
Peter Willis

Partner
UK

A partner in our Competition & EU Law practice group based in London, I bring over 25 years' experience of providing solutions for our clients in highly regulated and technically complex markets.

pieter erasmus Module
Pieter Erasmus

Senior Associate
UK

I am a senior associate in the Intellectual Property Group in London, with a focus on regulatory and commercial matters primarily in the life sciences and healthcare sectors.

The Pharmaceutical Intellectual Property and Competition Law Review provides a practical overview of pharmaceutical intellectual property issues, including patent linkage and exclusivities, and related competition concerns. With a focus on recent developments, it is a useful tool for managing global risks in this area – analysing the key elements of the relevant legal and regulatory regimes across major jurisdictions worldwide.

Our team of authors, Sally Shorthose, Peter Willis, Chris de Mauny and Pieter Erasmus have written the UK chapter of this publication.

Read the full chapter here

Latest insights

More Insights
Pills lined up on blue background

Ascertained and obvious – Full Court declots Australia’s law on routine steps

Nov 07 2024

Read More
mountain scape

European Union Artificial Intelligence Act Guide

Nov 06 2024

Read More

California’s AI bill vs. the EU AI Act: a cross-continental analysis of AI regulations

Nov 06 2024

Read More